JPS5614663B2 - - Google Patents

Info

Publication number
JPS5614663B2
JPS5614663B2 JP6372271A JP6372271A JPS5614663B2 JP S5614663 B2 JPS5614663 B2 JP S5614663B2 JP 6372271 A JP6372271 A JP 6372271A JP 6372271 A JP6372271 A JP 6372271A JP S5614663 B2 JPS5614663 B2 JP S5614663B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP6372271A
Other versions
JPS4829758A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP6372271A priority Critical patent/JPS5614663B2/ja
Priority to US281804A priority patent/US3929765A/en
Priority to FR7229858A priority patent/FR2150816B1/fr
Priority to DE2241097A priority patent/DE2241097A1/de
Priority to GB3893772A priority patent/GB1393449A/en
Publication of JPS4829758A publication Critical patent/JPS4829758A/ja
Publication of JPS5614663B2 publication Critical patent/JPS5614663B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
JP6372271A 1971-08-21 1971-08-21 Expired JPS5614663B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP6372271A JPS5614663B2 (ja) 1971-08-21 1971-08-21
US281804A US3929765A (en) 1971-08-21 1972-08-18 Novel 3-substituted-aminoazetidine derivatives and process for preparation thereof
FR7229858A FR2150816B1 (ja) 1971-08-21 1972-08-21
DE2241097A DE2241097A1 (de) 1971-08-21 1972-08-21 Neue 3-substituierte-aminoazetidinderivate und verfahren zu ihrer herstellung
GB3893772A GB1393449A (en) 1971-08-21 1972-08-21 3-aminoazetidines and methods for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6372271A JPS5614663B2 (ja) 1971-08-21 1971-08-21

Publications (2)

Publication Number Publication Date
JPS4829758A JPS4829758A (ja) 1973-04-19
JPS5614663B2 true JPS5614663B2 (ja) 1981-04-06

Family

ID=13237559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6372271A Expired JPS5614663B2 (ja) 1971-08-21 1971-08-21

Country Status (5)

Country Link
US (1) US3929765A (ja)
JP (1) JPS5614663B2 (ja)
DE (1) DE2241097A1 (ja)
FR (1) FR2150816B1 (ja)
GB (1) GB1393449A (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888773A (en) * 1972-04-27 1975-06-10 Mobil Oil Corp Nitrogen compounds linked to a heterocyclic ring as multifunctional additives in fuel and lubricant compositions
US4120968A (en) * 1975-07-31 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic alkylaminocyclobutenediones
US4727152A (en) * 1982-09-30 1988-02-23 A. H. Robins Company, Inc. Intermediates useful in the preparation of fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
FR2560194B1 (fr) * 1984-02-27 1987-08-07 Midy Spa 3-aminoazetidine, ses sels, procede pour leur preparation et intermediaires de synthese
FR2649100B1 (fr) * 1989-06-29 1994-03-04 Laboratorios Dr Esteve Sa Nouvelles azetidines, leur preparation et leur application comme intermediaires pour la preparation de composes avec activite antimicrobienne
WO1999019297A1 (en) * 1997-10-15 1999-04-22 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
WO2000063168A1 (en) * 1999-04-16 2000-10-26 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
KR101426408B1 (ko) * 2013-02-19 2014-08-07 한국과학기술연구원 4각 고리 질소 화합물, 이를 포함하는 우울증, 정신 질환, 조루증, 또는 신경병증성 통증의 예방 또는 치료용 약학 조성물, 및 상기 약학 조성물을 포함하는 제제
ES2864862T3 (es) 2013-03-12 2021-10-14 Celltaxis Llc Métodos de inhibición de la leucotrieno A4 hidrolasa
RU2696559C2 (ru) 2013-03-14 2019-08-05 Селтакссис, Инк. Ингибиторы лейкотриен а4-гидролазы
WO2014152518A2 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
EP3801559A4 (en) 2018-05-31 2022-03-02 Celltaxis, LLC METHOD FOR REDUCING LUNG EXACERBATIONS IN PATIENTS SUFFERING FROM RESPIRATORY DISEASE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481920A (en) * 1965-10-22 1969-12-02 Lilly Co Eli Azetidinones

Also Published As

Publication number Publication date
US3929765A (en) 1975-12-30
JPS4829758A (ja) 1973-04-19
FR2150816A1 (ja) 1973-04-13
GB1393449A (en) 1975-05-07
FR2150816B1 (ja) 1976-07-02
DE2241097A1 (de) 1973-03-08

Similar Documents

Publication Publication Date Title
ATA136472A (ja)
FR2150816B1 (ja)
AR196074A1 (ja)
AU3005371A (ja)
AU2742671A (ja)
AU2894671A (ja)
AU2941471A (ja)
AU2952271A (ja)
AU2485671A (ja)
AU2854371A (ja)
AU2415871A (ja)
AU2724971A (ja)
AU2726271A (ja)
AU2473671A (ja)
AU3038671A (ja)
AU3025871A (ja)
AR199640Q (ja)
AU2740271A (ja)
AR202997Q (ja)
AR192311Q (ja)
AU2963771A (ja)
AU2456871A (ja)
AU2455871A (ja)
AU2940971A (ja)
AU2938071A (ja)